第一单位：
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.;Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.;Harvard-MIT MD-PhD Program, Harvard Medical School, Boston, MA 02115, USA.;PhD Program in Biological and Biomedical Sciences, Division of Medical Sciences, Harvard Medical School, Boston, MA 02115, USA.
作者：
Samantha E,Hoffman [1]
;
Todd W,Dowrey [2]
;
Carlos,Villacorta Martin [3]
;
Kevin,Bi [4]
;
Breanna,Titchen [5]
;
Shreya,Johri [5]
;
Laura,DelloStritto [6]
;
Miraj,Patel [7]
;
Colin,Mackichan [8]
;
Stephanie,Inga [7]
;
Judy,Chen [7]
;
Grace,Grimaldi [8]
;
Sara,Napolitano [9]
;
Isaac,Wakiro [4]
;
Jingyi,Wu [9]
;
Jason,Yeung [9]
;
Asaf,Rotem [9]
;
Ewa,Sicinska [10]
;
Erin,Shannon [4]
;
Thomas,Clancy [11]
;
Jiping,Wang [11]
;
Sarah,Denning [12]
;
Lauren,Brais [12]
;
Naomi R,Besson [13]
;
Kathleen L,Pfaff [13]
;
Ying,Huang [14]
;
Katrina Z,Kao [15]
;
Scott,Rodig [10]
;
Jason L,Hornick [10]
;
Sebastien,Vigneau [9]
;
Jihye,Park [4]
;
Matthew H,Kulke [16]
;
Jennifer,Chan [12]
;
Eliezer M,Van Allen [4]
;
George J,Murphy [2]
作者单位：
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.;Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.;Harvard-MIT MD-PhD Program, Harvard Medical School, Boston, MA 02115, USA.;PhD Program in Biological and Biomedical Sciences, Division of Medical Sciences, Harvard Medical School, Boston, MA 02115, USA.
[1]
Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, MA 02118, USA.;Center for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA 02118, USA.
[2]
Center for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA 02118, USA.
[3]
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.;Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
[4]
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.;Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.;PhD Program in Biological and Biomedical Sciences, Division of Medical Sciences, Harvard Medical School, Boston, MA 02115, USA.
[5]
Harvard Pilgrim Health Care Institute, Boston, MA 02215, USA.
[6]
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.;Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA 02115, USA.;Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
[7]
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.;Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
[8]
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.;Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.;Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
[9]
Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
[10]
Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
[11]
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
[12]
Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
[13]
Molecular Pathology Core Laboratory, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
[14]
Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.;Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
[15]
Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, MA 02118, USA.
[16]
DOI
10.1126/sciadv.add9668
PMID
37756410
发布时间
2024-09-26
换一批
